Brain–computer interfacing

OpenBCI Unveils Galea, A New Platform that Brings Next Generation Biometrics to Mixed Reality

Retrieved on: 
Thursday, November 19, 2020
Surveillance, Brain–computer interfacing, Biometrics, Identification, OpenBCI, Eurotech, Science and technology, Articles, Branches of biology

Galea also includes robust SDKs to bring biometric data into common development environments and enable researchers and developers across industries to produce next generation experiences through neurotechnology.

Key Points: 
  • Galea also includes robust SDKs to bring biometric data into common development environments and enable researchers and developers across industries to produce next generation experiences through neurotechnology.
  • "I believe that head-mounted computers integrated with human consciousness will drive the next major technology paradigm shift.
  • We are providing the world with a playground for experimentation and development using multi-modal biometric data in tandem with next generation wearable displays."
  • Starting next year, OpenBCI will provide early access to researchers and developers aiming to leverage BCI combined with mixed reality for commercial and research applications.

Brain Scientific Aims to Expand into the EU Market, Retains Registration Firm in Europe

Retrieved on: 
Tuesday, November 17, 2020
Branches of biology, Neuroscience, Brain–computer interfacing, Neurotechnology, Electrophysiology, Neurophysiology, Psychiatric assessment, Electroencephalography

The agreement specifies that AFINA will act as an authorized representative for Brain Scientific in the European Union and assist with registering Brain Scientifics advanced EEG solutions in 32 countries in the European market.

Key Points: 
  • The agreement specifies that AFINA will act as an authorized representative for Brain Scientific in the European Union and assist with registering Brain Scientifics advanced EEG solutions in 32 countries in the European market.
  • The next generation NeuroCap by Brain Scientific is a hospital-grade disposable EEG headset featuring 22 electrodes and 19 active EEG channels.
  • The NeuroCap works alongside Brain Scientifics NeuroEEG, an amplifier device to initiate the EEG studies in less than five minutes.
  • Brain Scientific is a commercial-stage healthcare company with two FDA-cleared products, providing next-gen solutions to the neurology market.

EEG and EMG Devices Market Size, Share- Global Industry Analysis, Key Growth Drivers Trends, Segments, Emerging Technologies, Opportunity and Forecast 2020 to 2024 | Technavio

Retrieved on: 
Wednesday, November 4, 2020
Medical devices, Health, Branches of biology, Electrophysiology, Neurophysiology, Electrodiagnosis, Neurotechnology, Brain–computer interfacing, Electroencephalography

The EEG and EMG devices market is poised to grow by USD 740.48 million during 2020-2024 progressing at a CAGR of almost 9% during the forecast period.

Key Points: 
  • The EEG and EMG devices market is poised to grow by USD 740.48 million during 2020-2024 progressing at a CAGR of almost 9% during the forecast period.
  • View the full release here: https://www.businesswire.com/news/home/20201104005245/en/
    Technavio has announced its latest market research report titled Global EEG and EMG Devices Market 2020-2024 (Graphic: Business Wire)
    Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19.
  • Download Free Sample Report on COVID-19 Recovery Analysis
    The report on the EEG and EMG devices market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
  • The EEG and EMG devices market analysis include product segment, end-user segment, and geography landscape.

US Nuclear and Grapheton Brain Implants to Help Immobilized Patients

Retrieved on: 
Monday, November 2, 2020
Branches of biology, Biology, Electrophysiology, Neurophysiology, Neurotechnology, Brain–computer interfacing, Electrodiagnosis, Electrocorticography, Ecog, Brain, Implant

Neuroscientists stress there is a large unmet demand to develop implantable sensors and the artificial intelligence required to translate the brain signals into specific commands or actions.

Key Points: 
  • Neuroscientists stress there is a large unmet demand to develop implantable sensors and the artificial intelligence required to translate the brain signals into specific commands or actions.
  • Fortunately, Grapheton has already developed various types of implantable brain sensors, including ECoG (electrocorticography- monitoring the electrical activity of the brain), spinal stimulation probes, and brain chemical sensors, all of which are already in use at various research centers.
  • These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.
  • Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov , or the companys website at www.usnuclearcorp.com

Global Electroencephalography (EEG) Devices Market Worth USD 886.40 Million by 2024 | CAGR - 9%

Retrieved on: 
Monday, November 2, 2020
Manufacturing, Engineering, Branches of biology, Neuroscience, Neurotechnology, Electrophysiology, Brain–computer interfacing, Neurophysiology, Psychiatric assessment, Electroencephalography

The electroencephalography (EEG) devices market is poised to grow by USD 886.40 million during 2020-2024 progressing at a CAGR of about 9% during the forecast period.

Key Points: 
  • The electroencephalography (EEG) devices market is poised to grow by USD 886.40 million during 2020-2024 progressing at a CAGR of about 9% during the forecast period.
  • View the full release here: https://www.businesswire.com/news/home/20201102005157/en/
    Technavio has announced its latest market research report titled Global Electroencephalography (EEG) Devices Market 2020-2024 (Graphic: Business Wire)
    Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19.
  • Download Free Sample Report on COVID-19 Recovery Analysis
    The report on the electroencephalography (EEG) devices market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
  • This study identifies the growing demand for EEG procedures as one of the prime reasons driving the electroencephalography (EEG) devices market growth during the next few years.

Muse® by Interaxon Appoints Walter Greenleaf as Chief Science Officer

Retrieved on: 
Friday, October 30, 2020
Science, Software, Research, Alternative medicine, General Health, Health, Technology, Mobile, Wireless, Articles, Branches of biology, Brain–computer interfacing, Muse, Neuroscience, Meditation, Electroencephalography

Muse by Interaxon Inc., a leading consumer neurotechnology and meditation company, appoints neuroscientist and digital medicine expert Walter Greenleaf as Chief Science Officer.

Key Points: 
  • Muse by Interaxon Inc., a leading consumer neurotechnology and meditation company, appoints neuroscientist and digital medicine expert Walter Greenleaf as Chief Science Officer.
  • Playing a pivotal role in guiding external research initiatives and forging strategic partnerships, Greenleaf will continue to build on Interaxons credibility within the neuroscience community.
  • Walter brings tremendous knowledge and experience to Interaxon.
  • About Muse by Interaxon Inc.:
    At Muse, our team of neuroscientists, meditation teachers, and engineers develop state-of-the-art experiences using research-grade EEG technology.

Patients with Severe Paralysis Use Stentrode Brain-Computer Interface to Text, Email, Shop, Bank Online, First-in-human Study Reports

Retrieved on: 
Wednesday, October 28, 2020
Other Professional Services, Other Health, Technology, Radiology, Stem cells, Practice Management, Professional services, General Health, Other Technology, Cardiology, Science, Biotechnology, Other Science, Health, Research, Branches of biology, Neuroscience, Biology, Human–computer interaction, User interface techniques, Neuroprosthetics, Neural engineering, Brain–computer interfacing, Stent-electrode recording array, Brain–computer interface, Neuromodulation, Bioelectronics, Stentrode™, Synchron, Inc.

Synchron , a neurovascular bioelectronics medicine company, today announced publication of a first-in-human study demonstrating successful use of the Stentrode brain-computer interface (BCI), or neuroprosthesis.

Key Points: 
  • Synchron , a neurovascular bioelectronics medicine company, today announced publication of a first-in-human study demonstrating successful use of the Stentrode brain-computer interface (BCI), or neuroprosthesis.
  • The patients used the neuroprosthesis to resume daily tasks independently, including text messaging, online shopping and managing finances.
  • Following implantation and training, patients commenced unsupervised home use of the system from day 86 and day 71, respectively.
  • The only interventional neural interface platform, the Stentrode is designed to function as both a neuroprosthesis and neuromodulation device.

Brain Scientific Appoints Stuart Bernstein as VP of Marketing

Retrieved on: 
Tuesday, October 20, 2020
Branches of biology, Brain–computer interfacing, Neuroscience, Neurotechnology, Electroencephalography, Electrophysiology, Neurophysiology

NEW YORK, Oct. 20, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire Brain Scientific Inc. (OTCQB: BRSF ), a neurology-focused medical device and software company, today announced the appointment of Stuart Bernstein as Vice President of Marketing.

Key Points: 
  • NEW YORK, Oct. 20, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire Brain Scientific Inc. (OTCQB: BRSF ), a neurology-focused medical device and software company, today announced the appointment of Stuart Bernstein as Vice President of Marketing.
  • In this role, Bernstein will be responsible for Brain Scientifics overall marketing strategy and efforts to strengthen the companys market position.
  • The announcement comes just weeks after Brain Scientific launched the next generation NeuroCap - a hospital-grade disposable EEG headset with 22 electrodes and 19 active EEG channels.
  • Brain Scientific is a commercial-stage healthcare company with two FDA-cleared products, providing next-gen solutions to the neurology market.

Stratus To Be Preferred EEG Provider For NeuroX Online Neurology Healthcare System

Retrieved on: 
Thursday, October 15, 2020
Branches of biology, Articles, Brain–computer interfacing, Electroencephalography, Electrophysiology, Neurophysiology, Neurotechnology, Neurology, Telehealth

GRAND RAPIDS, Mich., Oct. 15, 2020 /PRNewswire/ --NeuroX, an online Neurology and Psychology clinic, and Stratus, the leader in home EEG testing, today announced that Stratus will partner with NeuroX to provide in-home video electroencephalogram (EEG) diagnostics to patients.

Key Points: 
  • GRAND RAPIDS, Mich., Oct. 15, 2020 /PRNewswire/ --NeuroX, an online Neurology and Psychology clinic, and Stratus, the leader in home EEG testing, today announced that Stratus will partner with NeuroX to provide in-home video electroencephalogram (EEG) diagnostics to patients.
  • NeuroX is American TelePhysicians' acclaimed online specialty care system, providingcomplete Neurology and Psychology care with online consultations for both outpatient and inpatient facilities using telemedicine EMR technology.
  • "Stratus is proud to be the preferred EEG provider for NeuroX," said Charlie Alvarez, Chief Executive Officer of Stratus.
  • Stratus is the nation's leading provider of ambulatory in-home video EEG and has served more than 60,000 patients across the U.S.

New scientific study shows brain injuries can be unbroken by innovative neuro-technologies

Retrieved on: 
Wednesday, October 14, 2020
Branches of biology, Biology, Neurotrauma, Brain–computer interfacing, National Research Council, Neuroimaging, Neurotechnology, Ryan D'Arcy, Neuroplasticity, Neuroscience

The research study published in Frontiers of Human Neuroscience is led by neuroscientist Dr. Ryan D'Arcy, and involves tracking Capt.

Key Points: 
  • The research study published in Frontiers of Human Neuroscience is led by neuroscientist Dr. Ryan D'Arcy, and involves tracking Capt.
  • Greene's neuroplasticity and his physical, cognitive and PTSD improvements as he rewires his brain using the latest and most advanced brain technologies.
  • The team tracked improvements in brain vital sign improvements usingNeuroCatch Platform (or NeuroCatch).NeuroCatch is a rapid objective measure of cognitive brain function.
  • "These brain imaging results provide valuable insight into the importance of unleashing the power of neuroplasticity to inspire countless people impacted by brain and mental health conditions."